Gastric Mucosal Changes in Patients With Dermatomyositis

Last updated: May 30, 2022
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Lupus

Idiopathic Inflammatory Myopathies

Collagen Vascular Diseases

Treatment

N/A

Clinical Study ID

NCT05402670
2021-0656
  • Ages 18-70
  • All Genders

Study Summary

There are a large number of reports in the literature that patients with dermatomyositis often have various malignant tumors, and reports of gastric cancer are not rare. At present, the widely recognized gastric cancer occurrence patterns are: normal gastric mucosa-chronic superficial gastritis-chronic atrophic gastritis-intestinal metaplasia-dysplasia-gastric cancer, so the research about the gastric mucosal performance of patients with dermatomyositis is clinically meaningful

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • 1、18-70years old，no gender limit. 2、Clinical diagnosis of dermatomyositis. 3、dermatomyositis group conform to 1 and 2，control group conform to 1 .

Exclusion

Exclusion Criteria:

  • Contraindications for gastroscopy.
  • Past history of malignant tumors of the esophagus and stomach and or history ofsurgery.
  • Pregnant or lactating women. ④ Participated in other clinical studies within 3 months. ⑤Patients cannot express their main complaints correctly andcannot cooperate with the research.

Study Design

Total Participants: 150
Study Start date:
June 01, 2022
Estimated Completion Date:
June 01, 2023

Connect with a study center

  • Second Affiliated Hospital of Zhejiang University School of Medicine

    Hangzhou, Zhejiang
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.